Abbreviated course of radiotherapy (RT) for breast cancer

Breast

Volumn 20, Issue SUPPL. 3, 2011, Pages

  Schoenfeld, Jonathan D ^a   Harris, Jay R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Hypofractionation; Radiation therapy (RT)

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; TAMOXIFEN;

AGE; ARM EDEMA; ARTICLE; BRACHIAL PLEXUS NEUROPATHY; BREAST CANCER; BREAST FIBROSIS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL PRACTICE; DISEASE COURSE; DISEASE FREE SURVIVAL; ERYTHEMA; ESTHETICS; EUROPE; EVIDENCE BASED MEDICINE; FATIGUE; FINANCIAL MANAGEMENT; GEOGRAPHY; HEART DISEASE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LYMPH NODE IRRADIATION; LYMPHADENECTOMY; LYMPHEDEMA; MASTALGIA; MASTECTOMY; MEDICAL SOCIETY; OVERALL SURVIVAL; PARTIAL BREAST IRRADIATION; PARTIAL MASTECTOMY; PATIENT PREFERENCE; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION ENERGY; RADIATION INJURY; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RETROSPECTIVE STUDY; RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; UNITED STATES;

EID: 80054851001     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/S0960-9776(11)70308-3     Document Type: Article

References (118)

1. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
2. Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER, Wolmark N Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N. Engl J Med 2002, 347(8):567-575.
3. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N. EnglJ Med 1997, 337(14):949-955.
4. Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999, 353(9165):1641-1648.
5. Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Nat/. Cancer Inst 2005, 97(2):116-126.
6. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi R, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001, 12(7):997-1003.
7. Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev 2010, 36(6):443-450.
8. Timmerman RD An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008, 18(4):215-222.
9. Bentzen SM, Turesson I, Thames HD Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis. Radiother Oncol 1990, 18(2):95-106.
10. Fletcher GH Hypofractionation: lessons from complications. Radiother Oncol 1991, 20(l):10-15.
11. Overgaard M, Bentzen SM, Christensen JJ, Madsen EH The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 1987, 9(1):1-11.
12. Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 1989, 16(4):253-267.
13. Whelan TJ, Levine M, Julian J, Kirkbride R, Skingley P The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. Cancer 2000, 88(10):2260-2266.
14. Wallace LM, Priestman SG, Dunn JA, Priestman TJ The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clin Oncol 1993, 5(4):228-233.
15. Kawase E, Karasawa K, Shimotsu S, Izawa H, Hirowatari H, Saito AI, et al. Estimation of anxiety and depression in patients with early stage breast cancer before and after radiation therapy. Breast Cancer 2010.
16. American Cancer Society Breast Cancer Facts & Figures 2009-2010 2009-2010, American Cancer Society, Atlanta.
17. Dwyer P, Hickey B, Burmeister E, Burmeister B Hypofractionated whole-breast radiotherapy: impact on departmental waiting times and cost. J Med Imaging Radiat Oncol 2010, 54(3):229-234.
18. Lievens Y Hypofractionated breast radiotherapy: financial and economic consequences. Breast 2010, 19(3):192-197.
19. Yarnold J, Haviland J Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy. Breast 2010, 19(3):176-179.
20. Whelan TJ, Kim D-H, Sussman J Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol 2008, 18(4):257-264.
21. Fowler JF The first James Kirk memorial lecture. What next in fractionated radiotherapy?. BrJ Cancer Suppl 1984, 6:285-300.
22. Miles EF, Lee WR Hypofractionation for prostate cancer: a critical review. Semin Radiat Oncol 2008, 18(l):41-47.
23. Nedzi LA The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice. Semin Radiat Oncol 2008, 18(4):265-272.
24. Khan A, Haffty BG Hypofractionation in adjuvant breast radiotherapy. Breast 2010, 19(3):168-171.
25. Yarnold J, Bentzen SM, Coles C, Haviland J Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys 2011 Jan l, 79(l):l-9.
26. Baillet F, Housset M, Maylin C, Boisserie G, Bettahar R, Delanian S, et al. The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients. IntJ Radiat Oncol Biol Phys 1990, 19(5):1131-1133.
27. Group ST, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371(9618):1098-1107.
28. Group ST, Bentzen SM, Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9(4):331-341.
29. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7(6):467-471.
30. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002, 94(15):1143-1150.
31. Whelan TJ, PignolJ-P Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010, 362(6):513-520.
32. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005, 75(1):9-17.
33. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. Lancet Oncol 2010, 11(3):231-240.
34. Goel A, Kaushal V, Hooda HS, Das BP Comparison of two radiation dose schedules in post mastectomy carcinoma of the breast. Indian J Med Sci 2000, 54(7):278-283.
35. Shahid A, Athar MA, Asghar S, Zubairi T, Murad S, Yunas N Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols. J Pak Med Assoc 2009, 59(5):282-287.
36. Wu J-x, Hui Z-g, Li Y-x, Yu Z-h [Post-mastectomy radiotherapy with different fractionated dose schemes in early breast cancerJ. Zhonghua Zhong Liu Za Zhi 2003, 25(3):285-288.
37. Plataniotis GA, Theofanopoulou M-A, Sotiriadou K, Kyrgias G Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results. Breast Cancer 2010, 17(1):42-47.
38. Ash DV, Benson EA, Sainsbury JR, Round C, Head C Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group. Clin Oncol R Coll Radiol GB 1995, 7(2):93-96.
39. Fujii O, Hiratsuka J, Nagase N, Tokiya R, Yoden E, Sonoo H, et al. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes. Breast Cancer 2008, 15(l):86-92.
40. Liau S-S, Cariati M, Noble D, Wilson C, Wishart GC Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer. Ann R Coll Surg Engl 2010, 92(7):562-568.
41. Livi L, Stefanacci M, Scoccianti S, Dicosmo D, Borghesi S, Nosi F, et al. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. Clin Oncol R Coll Radiol GB 2007, 19(2):120-124.
42. Magee B, Stewart AL, Swindell R Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers. Clin Oncol R Coll Radiol GB 1999, 11(l):40-45.
43. McBain CA, Young EA, Swindell R, Magee B, Stewart AL Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome. Clin Oncol R Coll Radiol GB 2003, 15(1):25-31.
44. Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996, 41(1):7-13.
45. Pinnaro R, Soriani A, Landoni V, Giordano C, Papale M, Marsella A, et al. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. J Exp Clin Cancer Res 2010, 29:9.
46. Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W A shorter fractionation schedule for postlumpectomy breast cancer patients. IntJ Radiat Oncol Biol Phys 2000, 47(5):1219-1228.
47. Yamada Y, Ackerman I, Franssen E, MacKenzie RG, Thomas G Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?. IntJ Radiat Oncol Biol Phys 1999, 44(1):99-104.
48. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26(14):2373-2378.
49. Gebski V, Lagleva M, Keech A, Simes J, Langlands A Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Natl Cancer Inst 2006, 98(l):26-38.
50. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J. Natl Cancer Inst 1996, 88(22):1659-1664.
51. Turnbull AR, Turner DT, Chant AD, Shepherd JM, Buchanan RB, Fraser JD Treatment of early breast cancer. Lancet 1978, 2(8079):7-9.
52. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J. Clin Oncol 2000, 18(6):1220-1229.
53. Yarnold J, Haviland J Hypofractionated adjuvant whole breast radiotherapy: progress and prospects. Acta Oncol 2010, 49(8):1288-1292.
54. Kumar S, Juresic E, Barton M, Shafiq J Management of skin toxicity during radiation therapy: a review of the evidence. J Med. Imaging Radiat Oncol 2010, 54(3):264-279.
55. Taher AN, El-Baradie MM, Essa H, Zaki O, Ezzat S Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results. J Egypt. Natl Cane Inst 2004, 16(3):178-187.
56. Fehlauer F, Tribius S, Alberti W, Rades D Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 2005, 181(10):625-631.
57. Fehlauer F, Tribius S, Holler U, Rades D, Kuhlmey A, Bajrovic A, et al. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. IntJ Radiat Oncol Biol Phys 2003, 55(3):651-658.
58. Powell S, Cooke J, Parsons C Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules. Radiother Oncol 1990, 18(3):213-220.
59. Osako T, Oguchi M, Kumada M, Nemoto K, Iwase T, Yamashita T Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy. SpnjClin Oncol 2008, 38(5):334-338.
60. Deantonio L, Gambaro G, Beldl D, Masini L, Tunesi S, Magnani C, et al. Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity. Radiat Oncol (London) 2010, 5:112.
61. Inomata T, Narabayashi I, Inada Y, Shimbo T, Takahashi M, Tatsumi T, et al. Patients' subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy: comparison with conventional fractionation. Breast Cancer 2008, 15(1):93-100.
62. Harris JR, Hellman S Put the "hockey stick" on ice. IntJ Radiat Oncol Biol Phys 1988, 15(2):497-499.
63. Paszat LF, Mackillop WJ, Groome PA, Schulze K, Holowaty E Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999, 43(4):755-762.
64. Paszat LF, Vallis KA, Benk VMA, Groome PA, Mackillop WJ, Wielgosz A A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 2007, 82(3):294-300.
65. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, et al. Radiation-related heart disease: current knowledge and future prospects. IntJ Radiat Oncol Biol Phys 2010, 76(3):656-665.
66. Marhin W, Wai E, Tyldesley S Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer. Int J Radiat Oncol Biol Phys 2007, 69(2):483-489.
67. Stokes EL, Tyldesley S, Woods R, Wai E, Olivotto IA Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys 2011, 80(2):403-409.
68. Demirci S, Nam J, Hubbs JL, Nguyen T, Marks LB Radiation-induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow-up duration. IntJ Radiat Oncol Biol Phys 2009, 73(4):980-987.
69. Shapiro C, Recht A Side effects of adjuvant treatment of breast cancer. Af. Engl J Med 2001, 344(26):1997-2008.
70. Pierce SM, Recht A, Lingos TI, Abner A, Vicini F, Silver B, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 1992, 23(5):915-923.
71. Gatecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zal-strokucki W Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer - a review. Acta Oncol 2006, 45(3):280-284.
72. Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?. Radiother Oncol 2004, 71(3):297-301.
73. Stoll BA, Andrews JT Radiation-induced Peripheral Neuropathy. Br Med J 1966, 1(5491):834-837.
74. Koukourakis MI, Giatromanolaki A, Kouroussis C, Kakolyris S, Sivridis E, Frangiadaki C, et al. Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients. IntJ Radiat Oncol Biol Phys 2002, 52(1):144-155.
75. Carling M, Goodare H, Ironside A, Millington J, Rogers C Quality of life after breast radiotherapy. Lancet Oncol 2010, 11(7):612. author reply 612-3.
76. Johansson S, Svensson H, Denekamp J Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys 2000, 48(3):745-750.
77. Jung H, Beck-Bornholdt HP, Svoboda V, Alberti W, Herrmann T Quantification of late complications after radiation therapy. Radiother Oncol 2001, 61(3):233-246.
78. Recht A Which breast cancer patients should really worry about radiation-induced heart disease-and how much?. J Clin Oncol 2006, 24(25):4059-4061.
79. Lorigan P, Califano R, Faivre-Finn C, Howell A, Thatcher N Lung cancer after treatment for breast cancer. Lancet Oncol 2010, 11(12):1184-1192.
80. Anders CK, Johnson R, Litton J, Phillips M, Bleyer A Breast cancer before age 40 years. Semin Oncol 2009, 36(3):237-249.
81. Smith BD, Bentzen SM, Correa CR, Hahn CA, Hardenbergh PH, Ibbott GS, et al. Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. IntJ Radiat Oncol Biol Phys 2010, 81(l):59-68.
82. Theberge V, Whelan T, Shaitelman SF, Vicini FA Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy. Semin Radiat Oncol 2011, 21(l):55-65.
83. Constantine C, Parhar P, Lymberis S, Fenton-Kerimian M, Han SC, Rosenstein BS, et al. Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast. Clin Breast Cancer 2008, 8(3):269-274.
84. Williamson D, Dinniwell R, Fung S, Pintilie M, Done SJ, Fyles AW Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ. Radiother Oncol 2010, 95(3):317-320.
85. Haviland JS, Yarnold JR, Bentzen SM Hypofractionated radiotherapy for breast cancer. Af. EnglJ Med 2010, 362(19):1843. author reply 1843-4.
86. Tyldesley S, Woods R, Speer C, Nichol A, Weir L, Olivotto I The impact of fractionation on local relapse for patients with grade 3 breast cancer. Cancer Res 2010, 70(24 suppl):352.
87. Johansson S, Svensson H, Larsson LG, Denekamp J Brachial plexopathy after postoperative radiotherapy of breast cancer patients-a long-term follow-up. Acta Oncol 2000, 39(3):373-382.
88. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). IntJ Radiat Oncol Biol Phys 2009, 74(4):987-1001.
89. Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or lessj. Clin Oncol 2002, 20(20):4141-4149.
90. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. Af. EnglJ Med 2004, 351(10):963-970.
91. Smith IE, Ross GM Breast radiotherapy after lumpectomy - no longer always necessary. Af. EnglJ Med 2004, 351(10):1021-1023.
92. Dodwell DJ, Dyker K, Brown J, Hawkins K, Cohen D, Stead M, et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 2005, 17(8):618-622.
93. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 1993, 5(5):278-283.
94. MacDonald S, Taghian AG Prognostic factors for local control after breast conservation: does margin status still matter?. J Clin Oncol 2009, 27(30):4929-4930.
95. Holloway CL, Panet-Raymond V, Olivotto I Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery. Breast 2010, 19(3):163-167.
96. Kirova YM, Campana F, Savignoni A, Laki F, Muresan M, Dendale R, et al. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2009, 75(1):76-81.
97. Ortholan C, Hannoun-Livi J-M, Ferrero J-M, Largillier R, Courdi A Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. IntJ Radiat Oncol Biol Phys 2005, 61(l):154-162.
98. Martin S, Mannino M, Rostom A, Tait D, Donovan E, Eagle S, et al. Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer. Cfin. Oncol R Coll Radiol GB 2008, 20(7):502-505.
99. Bartelink H, Horiot J-C, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25(22):3259-3265.
100. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van Den Bogaert W, Barillot I, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. Af. Engl J Med 2001, 345(19):1378-1387.
101. Romestaing R, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, et al. Role of a 10 Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Cfin. Oncol 1997, 15(3):963-968.
102. Dodwell DJ, Povall J, Gerrard G, Eastwood A, Langlands A Skin telangiectasia: the influence of radiation dose delivery parameters in the conservative management of early breast cancer. Clin Oncol R Coll Radiol GB 1995, 7(4):248-250.
103. Chadha M, Chadha M, Boolboi SK, Malamud S, Friedmann R, Osborne M, et al. Accelerated whole breast radition therapy (WBRT) for early-stage node-negative breast cancer?. American Society of Clinical Oncology Annual Meeting 2009, 1-3.
104. Corvo R, Ricchetti F, Doino D, Torielli R, Agostinelli S, Cavagnetto F, et al. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university. Anticancer Res 2010, 30(ll):4749-4753.
105. Formenti SC, Gidea-Addeo D, Goldberg JD, Roses DF, Guth A, Rosenstein BS, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007, 25(16):2236-2242.
106. Freedman GM, Anderson PR, Goldstein LJ, Ma C-M, Li J, Swaby RF, et al. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007, 68(2):347-353.
107. Lee LJ, Harris JR Innovations in radiation therapy (RT) for breast cancer. Breast 2009, 18(Suppl 3):S103-S111.
108. Croog VJ, Wu AJ, McCormick B, Beal KR Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast. IntJ Radiat Oncol Biol Phys 2009, 73(l):88-93.
109. Dewyngaert JK, Jozsef G, Mitchell J, Rosenstein B, Formenti SC Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results. IntJ Radiat Oncol Biol Phys 2007, 68(4):1251-1259.
110. James ML, Lehman M, Hider PN, Jeffery M, Hickey BE, Francis DP Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev 2010, 11:CD003860.
111. UK Clinical Research Network Study Portfolio: accessed January 27, 2011: http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=1466.
112. UK Clinical Research Network Study Portfolio: accessed January 27, 2011: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=2254.
113. US National Institutes of Health. accessed January 27, 2011: http://clinicaltrials.gov/ct2/show/NCT00470236.
114. US National Institutes of Health. accessed January 27, 2011: http://clinicaltrials.gov/ct2/show/NCT01247233.
115. Pierce LJ, Moughan J, White J, Winchester DP, Owen J, Wilson JF 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer. IntJ Radiat Oncol Biol Phys 2005, 62(l):183-192.
116. Yarnold JR, Price R, Steel GG Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Subcommittee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology. Clin Oncol R Coll Radiol GB 1995, 7(4):223-226.
117. van der Laan HP, Hurkmans CW, Kuten A, Westenberg HA Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 2010, 94(3):280-285.
118. Jagsi R, Makris A, Goldberg S, Taghian A Intra-European differences in the radiotherapeutic management of breast cancer: a survey study. Clin Oncol R Coll Radiol GB 2006, 18(5):369-375.